The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease ; volume:12 ; number:1 ; day:27 ; month:5 ; year:2020 ; pages:1-11 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (27.5.2020), 1-11, 12.2020
- Creator
-
Langbaum, Jessica B.
Ellison, Noel N.
Caputo, Angelika
Thomas, Ronald G.
Langlois, Carolyn
Riviere, Marie-Emmanuelle
Graf, Ana
Lopez Lopez, Cristina
Reiman, Eric M.
Tariot, Pierre N.
Hendrix, Suzanne B.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-020-00633-2
- URN
-
urn:nbn:de:101:1-2020080101380935182982
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Langbaum, Jessica B.
- Ellison, Noel N.
- Caputo, Angelika
- Thomas, Ronald G.
- Langlois, Carolyn
- Riviere, Marie-Emmanuelle
- Graf, Ana
- Lopez Lopez, Cristina
- Reiman, Eric M.
- Tariot, Pierre N.
- Hendrix, Suzanne B.
- SpringerLink (Online service)
Other Objects (12)
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Will cognitive mapping hinder Alzheimer’s Disease?
Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Will cognitive mapping hinder Alzheimer’s Disease?
Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Will cognitive mapping hinder Alzheimer’s Disease?
Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
Cognitive Blackouts in Mild Cognitive Impairment and Alzheimer’s Dementia
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease